Upstream Bio Appoints Allison Ambrose as General Counsel
December 17, 2024 08:00 ET
|
Upstream Bio
Upstream appoints Allison Ambrose as General Counsel
Upstream Bio Announces Addition to Russell 2000® Index
December 16, 2024 08:00 ET
|
Upstream Bio
Upstream Bio (Nasdaq:UPB) to be added to Russell 2000® index effective at the open of the U.S. equities market on Monday, December 23.
Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 21, 2024 08:00 ET
|
Upstream Bio
Upstream Bio CEO to participate in fireside chat at Piper Sandler
Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 07, 2024 07:00 ET
|
Upstream Bio
Upstream reports third quarter 2024 financial results and recent corporate achievements
Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 15, 2024 16:15 ET
|
Upstream Bio
Upstream closes $293 million upsized IPO including full exercise of underwriters’ option to purchase additional shares
Upstream Bio Announces Pricing of Upsized Initial Public Offering
October 10, 2024 19:35 ET
|
Upstream Bio
Upstream Bio announces pricing of upsized initial public offering
Upstream Bio Announces Oral Presentation of New Data from a Phase 1b Multiple Ascending Dose Trial of Verekitug (UPB-101) in Adults with Asthma at the European Respiratory Society Congress
September 09, 2024 08:00 ET
|
Upstream Bio, Inc.
Upstream gives oral presentation of clinical data for verekitug in patients with severe asthma at European Respiratory Society congress
Upstream Bio Presents Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society International Conference
May 22, 2024 11:15 ET
|
Upstream Bio, Inc.
Positive results from a Phase 1 dose ranging study of verekitug (UPB-101) in asthma presented at ATS 2024
Upstream Bio to Present Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society (ATS) International Conference
May 15, 2024 07:00 ET
|
Upstream Bio, Inc.
Upstream Bio will present clinical data from dose-ranging study of verekitug (UPB-101) in adults with asthma at the American Thoracic Society conference